Tuesday, October 6, 2026
Source trace. Via News points to the documents behind its reporting and shows what we drew from each — so you can check any claim. How we source
News articleYahoo Finance· January 5, 2026

Acer Announces New Lineup of Premium Swift AI Copilot+ PCs Featuring Intel Core Ultra Series 3 Processors

View original at finance.yahoo.com
Acer Announces New Lineup of Premium Swift AI Copilot+ PCs Featuring Intel Core Ultra Series 3 Processors Latest Swift AI series of thin-and-light laptops showcases sleek new designs, advanced features, and next-generation AI performance Editor's Summary The Acer Swift 16 AI is powered by up to Intel Core Ultra X9 Seri…
Opening lines of the source · Yahoo Finance · short snapshot — read the full document at the original

What we drew from this source

The claims Via News extracted from this document. We point to the source; we don't replace it.

  • Swift Edge 14 AI weighs under 1 kg, making it one of the lightest AI laptops in its class

    80% confidence
  • Swift 16 AI provides up to 24 hours battery life for video playback and up to 14 hours for web browsing

    80% confidence
  • The touchpad claim is based on Acer's internal market analysis as of December 15, 2025, comparing Swift 16 AI with 26 commercially available notebooks from major manufacturers

    80% confidence
  • Acer is one of the world's top technology companies with a presence in more than 160 countries

    80% confidence
  • Swift 16 AI features the world's largest haptic touchpad measuring 175.5mm x 109.7mm

    80% confidence

Cited in these Via News reports

What we know · the intelligence behind this page
Live from the substrate
What we're seeing
Obesity and Immunology Readouts, Big Pharma M&A and AI-Designed Drugs Converge Into a Q4 2026 Catalyst Wave
Late-stage data and deal activity are clustering ahead of Q4 2026. Novo Nordisk's CagriSema won Best Abstract at EASD 2026 for its brain and body (fMRI/MRI) data, Lilly showed ADtouch results for EBGLYSS and agreed to buy Merida Biosciences for $2.9B, and Merck's tulisokibart hit its Phase 2b endpoints. A key regulatory catalyst follows: the FDA PDUFA date for the ivonescimab BLA on 2026-11-14. AI-designed rentosertib showing anti-aging effects adds a speculative AI-drug-discovery thread, while QAIAx's microcities trial and QIII pilot (planned 2027-01-01) are peripheral, forecast-only items.
Our read on the data ›
Signals we're tracking
Satellite-Terrestrial Network Integration Acceleration
Increased investment and launches in hybrid satellite-cellular networks across telecom industry; competitive responses from other carriers; regulatory activity around satellite spectrum; expansion of emergency/rural connectivity use cases
Patterns we're watching ›
Where sources disagree
ING Group
Both facts record the same metric (shares_outstanding) for ING Group at the identical observation date (2025-12-31). FACT A states 2,902,437,688 shares; FACT B states 2,902 million shares (2,902,000,000). The difference is 437,688 shares (~0.015%). This is a genuine value conflict, though the discrepancy appears to result from FACT B rounding to the nearest million while FACT A provides the precise count.
We flag conflicts openly ›
Recently verified
✓ Checked against the original source
4,985
facts traced to their source — and we flag the ones that don't hold up.
101 entities tracked4,985 facts checked against source5,351 source documents archived
Query this data → isubstrate.com
Acer Announces New Lineup of Premium Swift AI Copilot+ PCs Featuring Intel Core Ultra Series 3 Processors — Source | Via News | Via News